BCA-225(CU-18),MMab

BCA-225 is a glycoprotein expressed in breast carcinoma and cervical cancer. It is a useful marker in the diagnosis of breast cancer and can also be used to differentiate between mesothelioma and adenocarcinoma, with the latter often being positive.

BCA-225(CU-18),MMab
BCA-225(CU-18),MMab

Intended Use

BCA-225 is a glycoprotein expressed in breast carcinoma and cervical cancer. It is a useful marker in the diagnosis of breast cancer and can also be used to differentiate between mesothelioma and adenocarcinoma, with the latter often being positive.


Storage & Validity

Store at 2~8°C. Avoid freezing. 

Maintain temperature below room temperature during transport, ensuring it does not exceed one week.

Specifications


Product Name            BCA-225(CU-18),MMab            
Clone            CU-18            
Catalog No.            CBM-0020            
Positive Site            Cytoplasm            
Applicable Tissue            Paraffin section            
Pre-treatment            Heat retrieval            
Format and Volume            Ready-to-use: 1mL, 3mL, 6mL             
  • Intended Use

  • Specifications

Related Product

Tel

Tel

4014414689
Email

Email

info@celnovte.com
Celnovte

Top

Partner with Celnovte

Partner with Celnovte

Elevate Your IHC Business with Proven Solutions & Global Support.

Contact us Celnovte